ada.enesco, Author at European Medical Journal - Page 50 of 65

Genetic Map Paves Way for Targeted GIST Treatment

A new molecular classification for gastrointestinal stromal tumours has uncovered four distinct subtypes and identified a potential tumour suppressor gene.

Study Finds Genetic Link to Multiple Myeloma Risk, Suggests Genetic Testing for High-Risk Patients

A recent study uncovers a genetic connection between multiple myeloma and inherited cancer predisposition syndromes.

Dysregulated Amino and Fatty Acid Metabolism in Late Pregnancy Linked to Type 2 Diabetes Risk

Dysregulation of certain amino and fatty acids in late pregnancy could influence the risk of developing Type 2 diabetes

Achieving Equity in Food Allergy Immunotherapy Trials

A recent review reveals significant racial and ethnic disparities in FOIT clinical trials.

Early Intervention with TAVR Improves Outcomes in Asymptomatic Severe Aortic Stenosis

Early transcatheter aortic-valve replacement is more effective than clinical surveillance in reducing adverse outcomes in patients with asymptomatic severe aortic stenosis.

Long-Term Ventilation Linked to Improved Survival in COPD-OSA Patients

Long-term PAP therapy may boost survival in patients with COPD and OSA, highlighting potential benefits of early diagnosis and proactive respiratory management.

AI Method Shows Promise in Predicting Prostate Cancer Prognosis

Using advanced MRI imaging, an AI segmentation algorithm was developed and trained to delineate specific tumour lesions.

SGLT2 Inhibitors Reduce Cardiovascular Risks in Patients with Type 2 Diabetes

New research has revealed that SGLT2is are associated with an 18% reduction in total cardiovascular disease risk compared with DPP4is.

Novel CAR-T Approach Shows Promise Against Paediatric AML

Recent research presents a groundbreaking CAR-T therapy for paediatric acute myeloid leukaemia, addressing the challenges posed by antigen variability.

Enhanced Method for Smartwatch-Based Glucose Monitoring

A Japan-based team has made strides in improving non-invasive blood glucose monitoring technology, a timely development as diabetes rates rise globally.